DAMYLIN AVEC CODEINE SIROP 12.5 MG / 5 ML
DIPHENHYDRAMINE HYDROCHLORIDE : 12.5 MG / 5 ML CODEINE PHOSPHATE : 3.3 MG / 5 ML AMMONIUM CHLORIDE : 125 MG / 5 ML · DIN 02245019 · LABORATOIRE ATLAS INC
Health Canada status: APPROVED
What is DAMYLIN AVEC CODEINE SIROP?
DAMYLIN AVEC CODEINE SIROP 12.5 MG / 5 ML contains DIPHENHYDRAMINE HYDROCHLORIDE : 12.5 MG / 5 ML CODEINE PHOSPHATE : 3.3 MG / 5 ML AMMONIUM CHLORIDE : 125 MG / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02245019, held by LABORATOIRE ATLAS INC, supplied as SYRUP for ORAL administration. Health Canada currently lists it as approved, status dated 16-Nov-2001. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What else is DAMYLIN AVEC CODEINE SIROP called?
The same molecule, OPIUM DERIVATIVES AND EXPECTORANTS, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Dropizol | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02245019 |
|---|---|
| Brand name | DAMYLIN AVEC CODEINE SIROP |
| Generic / active ingredient | DIPHENHYDRAMINE HYDROCHLORIDE : 12.5 MG / 5 ML CODEINE PHOSPHATE : 3.3 MG / 5 ML AMMONIUM CHLORIDE : 125 MG / 5 ML |
| Manufacturer | LABORATOIRE ATLAS INC |
| Strength | 12.5 MG / 5 ML |
| Dosage form | SYRUP |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS |
| AHFS class | 84:04.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 16-Nov-2001 |
| Original market date | 2001-12-01 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02245019 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2245019 |
| Brand name | DAMYLIN AVEC CODEINE SIROP |
| Active ingredient / INN | DIPHENHYDRAMINE HYDROCHLORIDE : 12.5 MG / 5 ML CODEINE PHOSPHATE : 3.3 MG / 5 ML AMMONIUM CHLORIDE : 125 MG / 5 ML |
| ATC code | R05FA02 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R05 |
| AHFS class | 84:04.92 |
| Health Canada schedule | NARCOTICS (CDSA I) |
| Biosimilar biologic | No |
| Market authorization holder | LABORATOIRE ATLAS INC |
Which pack is which?
| Strength on the label | 12.5 MG / 5 ML |
|---|---|
| Dosage form | SYRUP |
| Route | ORAL |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
What can be used instead?
Other Canadian products sharing ATC code R05FA02 OPIUM DERIVATIVES AND EXPECTORANTS. 25 of 156 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION | 200 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02265419 |
| BENYLIN EXTRA STRENGTH COUGH & CHEST CONGESTION WITH WARMING SENSATION | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02003317 |
| BENYLIN EXTRA STRENGTH COUGH COMPLETE | 200 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02265400 |
| BENYLIN EXTRA STRENGTH FOR PEOPLE WITH DIABETES | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02436485 |
| BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 02320959 |
| BENYLIN REGULAR STRENGTH COUGH PLUS CHEST CONGESTION RELIEF | 15 MG / 5 ML | SYRUP | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | MARKETED | DIN 01944762 |
| CALMYLIN | 12.5 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 00535230 |
| CALMYLIN ACE | 10 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 02198630 |
| CALMYLIN PSE WITH CODEINE | 3.3 MG / 5 ML | SYRUP | TEVA CANADA LIMITED | MARKETED | DIN 02172917 |
| COUGH & CHEST CONGESTION | 20 MG / 20 ML | SYRUP | JUNO OTC INC | MARKETED | DIN 02539195 |
How much does OPIUM DERIVATIVES AND EXPECTORANTS cost around the world?
OPIUM DERIVATIVES AND EXPECTORANTS is listed on 2 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Iceland publishes a max wholesale; Romania publishes a max producer price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Romania | max producer price | 1 | 4 | RON███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
5 pack listings across 2 brand entries and 2 price bases, refreshed 03 Sep 2026. Ranges span every OPIUM DERIVATIVES AND EXPECTORANTS pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.